VESSEL WALL-DEPENDENT METABOLIC PATHWAYS OF THE ADHESIVE PROTEINS, VON-WILLEBRAND-FACTOR AND VITRONECTIN

被引:0
作者
PREISSNER, KT
POTZSCH, B
机构
关键词
VON-WILLEBRAND-FACTOR; VITRONECTIN; VESSEL WALL; METABOLIC PATHWAY; MULTIMERIZATION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The integrity of the vessel wall under quiescent conditions as well as its appropriate responsiveness under conditions of stimulation, inflammation or vascular injury is controlled by a number of adhesive interactions involving distinct cellular receptor systems and various multifunctional adhesive ligands. While a number of these extracellular matrix components of the vessel wall are endogenously produced, secreted and deposited, exogenous adhesion proteins may become translocated from the intra- to the extravascular space by virtue of endothelial cell-specific transport systems. Two prominent examples for each metabolic pathway are discussed. Endothelial cell-specific biosynthesis and secretion as well as deposition of multimeric von-Willebrand-factor within intracellular granules (Weibel-Palade bodies) relates to the first possibility of processing, whereas binding of reactive forms of circulating vitronectin to diverse cellular receptors with subsequent extravasation and deposition into the extracellular matrix appears to be characteristic for the second case, In this review the known features of the metabolic routes of both adhesion proteins are discussed and set in perspective to their functional properties. Their localized mode of action in the vessel wall appears to be crucial for balanced haemostasis and immune systems, two major defence mechanisms of the organism.
引用
收藏
页码:239 / 251
页数:13
相关论文
共 102 条
[1]  
BARIETY J, 1989, CLIN EXP IMMUNOL, V75, P76
[2]   HUMAN SPREADING FACTOR - SYNTHESIS AND RESPONSE BY HEPG2 HEPATOMA-CELLS IN CULTURE [J].
BARNES, DW ;
REING, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 125 (02) :207-214
[3]   THROMBIN IMMOBILIZED TO EXTRACELLULAR-MATRIX IS A POTENT MITOGEN FOR VASCULAR SMOOTH-MUSCLE CELLS - NONENZYMATIC MODE OF ACTION [J].
BARSHAVIT, R ;
BENEZRA, M ;
ELDOR, A ;
HYAM, E ;
FENTON, JW ;
WILNER, GD ;
VLODAVSKY, I .
CELL REGULATION, 1990, 1 (06) :453-463
[4]  
BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565
[5]  
BONFANTI R, 1989, BLOOD, V73, P1109
[6]   STRUCTURE OF PRE-PRO-VON WILLEBRAND FACTOR AND ITS EXPRESSION IN HETEROLOGOUS CELLS [J].
BONTHRON, DT ;
HANDIN, RI ;
KAUFMAN, RJ ;
WASLEY, LC ;
ORR, EC ;
MITSOCK, LM ;
EWENSTEIN, B ;
LOSCALZO, J ;
GINSBURG, D ;
ORKIN, SH .
NATURE, 1986, 324 (6094) :270-273
[7]  
BRUNNER G, 1994, BLOOD COAGUL FIBRIN, V5, P625
[8]   PLASMIN CLEAVAGE OF VITRONECTIN - IDENTIFICATION OF THE SITE AND CONSEQUENT ATTENUATION IN BINDING PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
CHAIN, D ;
KREIZMAN, T ;
SHAPIRA, H ;
SHALTIEL, S .
FEBS LETTERS, 1991, 285 (02) :251-256
[9]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I STABILIZES VITRONECTIN-DEPENDENT ADHESIONS IN HT-1080 CELLS [J].
CIAMBRONE, GJ ;
MCKEOWNLONGO, PJ .
JOURNAL OF CELL BIOLOGY, 1990, 111 (05) :2183-2195
[10]  
CONFORTI G, 1992, BLOOD, V80, P437